India faces one of the world's largest burdens of type-2 diabetes, with an estimated 101 million adults affected, second only to China. At the same time, obesity and its metabolic consequences are ...

Ozempic, the globally sought-after semaglutide injection that has dominated conversations around diabetes care and weight loss, has finally entered the Indian market. With it, an immediate surge of ...